Devices, systems and methods for medicament delivery

Information

  • Patent Grant
  • 8544645
  • Patent Number
    8,544,645
  • Date Filed
    Friday, May 4, 2012
    12 years ago
  • Date Issued
    Tuesday, October 1, 2013
    11 years ago
Abstract
An apparatus includes a container defining an internal region configured to contain multiple medicament delivery devices, such as, for example, pen injectors, auto-injectors, inhalers or the like. The container includes an electronic circuit system configured to output a first electronic output associated with a first medicament delivery device contained within the internal region when the first medicament delivery device is removed from the internal region of the container. The electronic circuit system is further configured to output a second electronic output associated with a second medicament delivery device contained within the internal region when the second medicament delivery device is removed from the internal region of the container. The second electronic output is different than the first electronic output. At least one of the first electronic output or the second electronic output is associated with a use instruction.
Description
BACKGROUND

The invention relates generally to a medical device, and more particularly to a container for containing medicament delivery devices.


Exposure to certain substances, such as, for example, peanuts, shellfish, bee venom, certain drugs, toxins, and the like, can cause allergic reactions in some individuals. Such allergic reactions can, at times, lead to anaphylactic shock, which can cause a sharp drop in blood pressure, hives, and/or severe airway constriction. Accordingly, responding rapidly to mitigate the effects from such exposures can prevent injury and/or death. For example, in certain situations, an injection of epinephrine (i.e., adrenaline) can provide substantial and/or complete relief from the allergic reaction. In other situations, for example, an injection of an antidote to a toxin can greatly reduce and/or eliminate the harm potentially caused by the exposure. Because emergency medical facilities may not be available when an individual is suffering from an allergic reaction, some individuals carry a medicament delivery device, such as, for example, an auto-injector, to rapidly self-administer a medicament in response to an allergic reaction.


For a variety of reasons, however, some individuals who are susceptible to allergic reactions may not carry such a medicament delivery device. For example, some individuals may not be aware of their susceptibility to allergic reactions. Other individuals may be are aware of their susceptibility but may, at times, forget to carry a medicament delivery device and/or leave it in a location where it is impractical to use in an emergency. In some situations, the consequences of an individual leaving home without having a medicament delivery device can be compounded when, for example, the individual is going to an environment that poses a greater likelihood of exposure to the substances that can trigger an allergic reaction. For example, an individual who is allergic to peanuts may be at a much greater risk when eating at a restaurant than when eating at home.


Moreover, some known medicament delivery devices require several steps to deliver the medicament into the patient. For example, to actuate some known auto-injectors, the user must remove a protective cap, remove a locking device, place the auto-injector in a proper position against the body and then press a button to actuate the auto-injector. Failure to complete these operations properly can result in an incomplete injection and/or injection into an undesired location of the body. In certain instances, for example, users who have become confused in the operation of some known auto-injectors have inadvertently injected the medicament into their thumb by improperly positioning the auto-injector.


The likelihood of improper use of known medicament delivery devices can be compounded by the nature of the user and/or the circumstances under which such devices are used. For example, many users are not trained medical professionals and may have never been trained in the operation of such devices. Moreover, in certain situations, the user may not be the patient, and may therefore have no experience with the medicament delivery device. Similarly, because some known medicament delivery devices are configured to be used relatively infrequently in response to an allergic reaction or the like, even those users familiar with the device and/or who have been trained may not be well practiced at operating the device. Finally, such devices are often used during an emergency situation, during which even experienced and/or trained users may be subject to confusion, panic and/or the physiological effects of the condition requiring treatment.


Some known medicament delivery devices include printed instructions to inform the user of the steps required to properly deliver the medicament. Such printed instructions, however, can be inadequate for the class of users and/or the situations described above. Moreover, because some known medicament delivery devices, such as, for example, auto-injectors, pen injectors, inhalers or the like, can be compact, such printed instructions may be too small to read and comprehend during an emergency situation.


Thus, a need exists for a container for medicament delivery devices that can be located in environments in which some individuals may have a higher than normal risk of having an allergic reaction. Additionally, such containers should provide instructions for using the medicament delivery devices contained therein that can be easily understood by an untrained user in any type of situation.


SUMMARY

Apparatuses for containing medicament delivery devices are described herein. In one embodiment, an apparatus includes a container defining an internal region configured to contain multiple medicament delivery devices, such as, for example, pen injectors, auto-injectors, inhalers or the like. The container includes an electronic circuit system configured to output a first electronic output associated with a first medicament delivery device contained within the internal region when the first medicament delivery device is removed from the internal region of the container. The electronic circuit system is further configured to output a second electronic output associated with a second medicament delivery device contained within the internal region when the second medicament delivery device is removed from the internal region of the container. The second electronic output is different than the first electronic output. At least one of the first electronic output or the second electronic output is associated with a use instruction of the first medicament delivery device and/or the second medicament delivery device.





BRIEF DESCRIPTION OF THE DRAWINGS


FIGS. 1-3 are schematic illustrations of a medical device according to an embodiment of the invention in a first configuration, a second configuration and a third configuration, respectively.



FIGS. 4-6 are schematic illustrations of a medical device according to an embodiment of the invention in a first configuration, a second configuration and a third configuration, respectively.



FIG. 7 is a schematic illustration of a medical device according to an embodiment of the invention.



FIG. 8 is a perspective view of a medical device according to an embodiment of the invention in a first configuration.



FIG. 9 is a perspective view of the medical device shown in FIG. 8 in a second configuration.



FIG. 10 is a perspective view of the medical device shown in FIG. 8 in a third configuration.



FIG. 11 is a schematic illustration of a portion of a medical device according to an embodiment of the invention.



FIGS. 12-14 are schematic illustrations of a medical device according to an embodiment of the invention in a first configuration, a second configuration and a third configuration, respectively.





DETAILED DESCRIPTION

In some embodiments, an apparatus includes a container defining an internal region configured to contain multiple medicament delivery devices, such as, for example, pen injectors, auto-injectors, inhalers or the like. The container includes an electronic circuit system configured to output a first electronic output associated with a first medicament delivery device contained within the internal region when the first medicament delivery device is removed from the internal region of the container. The electronic circuit system is further configured to output a second electronic output associated with a second medicament delivery device contained within the internal region when the second medicament delivery device is removed from the internal region of the container. The second electronic output is different than the first electronic output. At least one of the first electronic output or the second electronic output is associated with a use instruction of the first medicament delivery device and/or the second medicament delivery device.


In some embodiments, an apparatus includes a container defining an internal region configured to contain multiple medicament delivery devices. The container includes an electronic circuit system configured to output a first electronic output associated with a first medicament delivery device contained within the internal region when the first medicament delivery device is removed from the internal region of the container. The first medicament delivery device includes a label configured to output a signal associated with at least one of a contents of the first medicament delivery device, an expiration date of the first medicament delivery device, a dosage of the first medicament delivery device or a use instruction associated with the first medicament delivery device. In this manner, the first electronic output can be associated with the signal received by the electronic circuit system. The electronic circuit system is further configured to output a second electronic output associated with a second medicament delivery device contained within the internal region when the second medicament delivery device is removed from the internal region of the container. The second electronic output is different than the first electronic output. At least one of the first electronic output or the second electronic output is associated with a use instruction of the first medicament delivery device and/or the second medicament delivery device.


In some embodiments, a kit includes a medicament delivery device and a container. The container defines an internal region configured to contain the medicament delivery device. The container includes a movable portion, an electronic circuit system, a first switch and a second switch. The movable portion has a first position, in which the movable portion covers the internal region of the container, and a second position, in which the internal region of the container is exposed to an area outside the container. The first switch is configured to move between a first state and a second state when the movable portion moves between its first position and its second position. The first switch is operatively coupled to the electronic circuit system such that the electronic circuit system is configured to output a first electronic output when the first switch is moved from its first state to its second state. The first electronic output can be, for example, a visual output, an audible output or a haptic output. The second switch is configured to move between a first state and a second state when the medicament delivery device is removed from the internal region of the container. The second switch is operatively coupled to the electronic circuit system such that the electronic circuit system is configured to output a second electronic output when the second switch is moved from its first state to its second state. The second electronic output, which includes an instruction for using the medicament delivery device, can be, for example, a visual output (e.g. a video showing the proper use of the medicament delivery device), an audible output (e.g., a voice recording providing instructions for use) or a haptic output (e.g., a vibration indicating the location of a particular item).


In some embodiments, an apparatus includes a container, a retainer and an electronic circuit system. The container defines an internal region configured to contain at least a portion of a medicament delivery device, such as, for example a pen injector. The retainer is configured to be movably coupled to the container and to retain the portion of the medicament delivery device within the internal region defined by the container. The electronic circuit system is configured to output a first electronic output when the retainer is moved relative to the container and a second electronic output when the medicament delivery device is removed from the internal region. At least one of the first electronic output or the second electronic output is associated with an instruction for using the medicament delivery device.


In some embodiments, an apparatus includes a container, a retainer, an electronic circuit system and a label. The container defines an internal region configured to contain at least a portion of a medicament delivery device, such as, for example a pen injector. The retainer is configured to be movably coupled to the container and to retain the portion of the medicament delivery device within the internal region defined by the container. The label is configured to be coupled to the medicament delivery device and contain information associated with the medicament delivery device in a machine-readable format. The electronic circuit system is configured to output a first electronic output when the retainer is moved relative to the container and a second electronic output when the medicament delivery device is removed from the internal region. The electronic circuit system is further configured to receive the information contained on the label include at least a portion of the information in the first electronic output and/or the second electronic output. At least one of the first electronic output or the second electronic output is associated with an instruction for using the medicament delivery device.



FIGS. 1-3 are schematic illustrations of a medical device 100 according to an embodiment of the invention in a first configuration, a second configuration and a third configuration, respectively. The medical device 100 includes a container 110 including an electronic circuit system 130 and defining an internal region 112. The internal region 112 is configured to contain one or more medicament delivery devices. Disposed within the internal region 112 are at least a first medicament delivery device 150 and a second medicament delivery device 152. The first medicament delivery device 150 and/or the second medicament delivery device 152 can be any suitable medicament delivery device, such as, for example, an auto-injector, a pen injector, an inhaler or the like.


As shown in FIG. 2, the electronic circuit system 130 is configured to output a first electronic output OP1 when the first medicament delivery device 150 is removed from the internal region 112 of the container 110, as indicated by the arrow A. As discussed in more detail herein, the first electronic output OP1 can be associated with an identification of the first medicament delivery device 150, an identification of a physical condition and/or an instruction for using the first medicament delivery device 150. Moreover, the first electronic output OP1 can include a visual output, an audible output and/or a haptic output. For example, in some embodiments, the first electronic output OP1 can be associated with an audible message instructing a user in the use of the first medicament delivery device 150. Such an audible message can state, for example, “You have removed an auto-injector containing Epinephrine. To actuate the auto-injector, first remove the red safety tab located at the end of the auto-injector.” In other embodiments, for example, the first electronic output OP1 can be associated with a visual text message instructing to perform a series of tests on and/or observe the symptoms exhibited by a patient to determine whether the patient is suffering from a certain physical condition (e.g., anaphylactic shock).


Similarly, as shown in FIG. 3, the electronic circuit system 130 is configured to output a second electronic output OP2 when the second medicament delivery device 152 is removed from the internal region 112 of the container 110, as indicated by the arrow B. The second electronic output OP2, which is different than the first electronic output OP1, can include a visual output, an audible output and/or a haptic output. Moreover, as with the first electronic output OP1, the second electronic output OP2 can be associated with at least one of an identification of the second medicament delivery device 152, an identification of a physical condition and/or an instruction for using the second medicament delivery device 152. In this manner, the electronic circuit system 130 can provide the user with information about the particular medicament delivery device that has been removed from the container 110.


Although the second electronic output OP2 is described as being different than the first electronic output OP1, in some embodiments, the second electronic output OP2 can be the same as the first electronic output OP1. In some embodiments, for example, the second electronic output OP2 can include the same information as previously output via the first electronic output OP1 along with additional information. In this manner, the second electronic output OP2 can confirm the instructions and/or information provided by the first electronic output OP1.


The container 110 can be any container suitable for containing a plurality of medicament delivery devices. For example, in some embodiments, the container 110 can be a box-like structure that includes a lid or cover that can be repeatedly opened and closed to selectively expose the internal region 112 of the container 110 to an area outside the container 110. In other embodiments, the container 110 can include a frangible portion that can be irreversibly moved to expose the internal region 112 of the container 110 to allow access to the first medicament delivery device 150 and/or the second medicament delivery device 152.


The container 110 can be either portable or permanently installed at a particular location. For example, in some embodiments, the container 110 can be configured to be moved by the user. For example, in such embodiments, a user may carry the container 110 to events, such as picnics, field trips, children's camps or the like, where the likelihood of use increases. In other embodiments, the container 110 can be removably coupled to a mounting area within a building, such as a restaurant, airport and/or shopping mall. In this manner, when a user recognizes an emergency situation, the user can locate the container 110 and move it to the area in which the emergency situation is occurring. In yet other embodiments, the container 110 can be permanently coupled to a wall of a building.


The container 110 can be constructed from any suitable material, such as, for example, plastic, metal alloys, insulative foam, fabric or any combination thereof. In some embodiments, for example, the container 110 can include a hard, plastic outer casing and an insulative, shock-absorbing inner liner. In some embodiments, the container 110 can be constructed from a waterproof material and/or can be configured to float. In some embodiments, the container 110 can be constructed from a material configured to prevent light from reaching the interior region 112 of the container. In this manner, the container can prevent the medicaments contained therein from being exposed to light that can impact the chemical structure and/or stability of the medicament.


Although the container 110 is shown and described above as containing a first medicament delivery device 150 and a second medicament delivery device 152 having similar sizes and/or shapes, in some embodiments, a container can be configured to include medicament delivery devices of different sizes and/or shapes. For example, in some embodiments, a container can be configured to include a medical injector having a long, narrow shape and an inhaler having a wider shape.



FIGS. 4-6 are schematic illustrations of a medical device 200 according to one such embodiment of the invention in a first configuration, a second configuration and a third configuration, respectively. The medical device 200 includes a container 210 including an electronic circuit system 230 and defining an internal region 212. The internal region 212 includes a first retainer 214 and a second retainer 216. The first retainer 214 retains a first medicament delivery device 250 within the internal region 212 of the container. Similarly, the second retainer 216 retains a second medicament delivery device 252 within the internal region 212 of the container.


The electronic circuit system 230 includes a first switch 236 associated with the first retainer 214 and a second switch 237 associated with the second retainer 216. The first switch 236 is configured move between a first state (e.g., closed) and a second state (e.g., opened) when the first medicament delivery device 250 is removed from the first retainer 214. Similarly, the second switch 237 is configured move between a first state and a second state when the second medicament delivery device 252 is removed from the second retainer 216. In this manner, the electronic circuit system 230 can output electronic outputs based on the state of the first switch 236 and/or the second switch 237.


More particularly, as shown in FIG. 5, the electronic circuit system 230 is configured to output a first electronic output OP3, of the type described above, when the first medicament delivery device 250 is removed from the first retainer 214, as indicated by the arrow C. Similarly, as shown in FIG. 6, the electronic circuit system 230 is configured to output a second electronic output OP4, of the type described above, when the second medicament delivery device 252 is removed from the second retainer 216, as indicated by the arrow D. Said another way, the electronic circuit system 230 is configured to output the first electronic output OP3 in response to the first switch 236 moving between its first state and its second state. Similarly, the electronic circuit system 230 is configured to output the second electronic output OP4 in response to the second switch 237 moving between its first state and its second state.


The first retainer 214 can be any structure that cooperates with the first medicament delivery device 250 to retain the first medicament delivery device 250 within the internal region 212 of the container 210. Similarly, the second retainer 216 can be any structure that cooperates with the second medicament delivery device 252 to retain the second medicament delivery device 252 within the internal region 212 of the container 210. In some embodiments, for example, the first retainer 214 can be a recessed portion (not shown in FIGS. 4-6) of the internal region 212 having a shape to receive at least a portion of the first medicament delivery device 250. Such a recess can include, for example, an edge, a contour or a ridge that forms an interference fit with a portion of the first medicament delivery device 250 when the first medicament delivery device 250 is received within the first retainer 214. In other embodiments, for example, the first retainer 214 and/or the second retainer 216 can be a clip configured to engage a portion of the first medicament delivery device 250 and/or the second medicament delivery device 252, respectively, to retain the first medicament delivery device 250 and/or the second medicament delivery device 252 in the internal region 212. In yet other embodiments, the first retainer 214 and/or the second retainer 216 can be an elastic member, such as an elastic band configured to engage a portion of the first medicament delivery device 250 and/or the second medicament delivery device 252. In yet other embodiments, the first retainer 214 and/or the second retainer 216 can include a frangible member, such as a removable plastic covering configured to retain the first medicament delivery device 250 and/or the second medicament delivery device 252 in the internal region 212.


In some embodiments, the first retainer 214 can be uniquely associated with the first medicament delivery device 250 and/or the second retainer 214 can be uniquely associated with the second medicament delivery device 252. In this manner, the first medicament delivery device 250 can only be associated with the first switch 236 and the second medicament delivery device 252 can only be associated with the second switch 237. Said another way, such an arrangement prevents second medicament delivery 252 from inadvertently being retained by the first retainer 214, which could result in the electronic circuit system 230 outputting the first electronic output OP3 when the second medicament delivery device 252 is removed from the container 210 or vice-versa. Moreover, by using the first retainer 214 and the second retainer 216, the internal region 212 can be adapted to contain a variety of different medicament delivery devices having different sizes, shapes and/or characteristics. For example, in those embodiments in which the first retainer 214 is a recessed portion of the internal region 212, the shape of the recess can be uniquely associated with a shape of the first medicament delivery device 250, thereby preventing the second medicament delivery device 252 from being received within the first retainer 214. Similarly, in some embodiments, the second retainer 216 can be a recessed portion of the internal region 212, of the type described above, having a shape to receive at least a portion of the second medicament delivery device 252.


Although the retainers are described above as cooperating with the medicament delivery devices to retain the medicament delivery devices within the internal region 212 of the container 210, in some embodiments, the first retainer 214 and/or the second retainer 216 can perform additional functions. For example, in some embodiments, the first retainer 214 can electronically couple an electronic circuit system (not shown in FIGS. 4-6) disposed on the first medicament delivery device 250 to the electronic circuit system 230. The electronic circuit system included in the first medicament delivery device 250 can be of the type shown and described in U.S. patent application Ser. No. 11/621,236, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Jan. 9, 2007, which is incorporated herein by reference in its entirety. Similarly, the second retainer 216 can electronically couple an electronic circuit system (not shown in FIGS. 4-6) disposed on the second medicament delivery device 252 to the electronic circuit system 230. In this manner, the first retainer 214 and/or the second retainer 216 can be used as a battery charging port, a data exchange port or the like.



FIG. 7 is a schematic illustration of a medical device 300 according to an embodiment of the invention. Because the medical device 300 is similar in many respects to the medical devices shown and described above, the medical device 300 is shown in only one configuration. The medical device 300 includes a container 310 including an electronic circuit system 330 and defining an internal region 312. The internal region 312 includes a first medicament delivery device 350 and a second medicament delivery device 352 of the types described above.


The electronic circuit system 330 is configured to output a first electronic output (not shown in FIG. 7), of the type described above, when the first medicament delivery device 350 is removed from the internal region 312 of the container 310. Similarly the electronic circuit system 330 is configured to output a second electronic output (not shown in FIG. 7), of the type described above, when the second medicament delivery device 352 is removed from the internal region 312 of the container 310.


Moreover, as shown in FIG. 7, the first medicament delivery device 350 includes a label 354, such as, for example, a radio frequency identification (“RFID”) tag, configured to output a signal S that can be received by the electronic circuit system 330. In some embodiments, the signal S can indicate the position of the first medicament delivery device 350 (e.g., whether the first medicament delivery device 350 is outside the internal region 312). In other embodiments, the signal S can include information characterizing the first medicament delivery device 350. For example, in some embodiments, the signal S can be associated with the contents of the first medicament delivery device 350 (e.g., the amount and type of medicament contained therein), an expiration date of the first medicament delivery device 350, a dosage of the first medicament delivery device 350 and/or a use instruction associated with the first medicament delivery device 350. In this manner, the electronic circuit system 330 can receive the signal S and produce the first electronic output (not shown in FIG. 7) to include information contained within the signal S. Said another way, this arrangement allows the electronic circuit system 330 to produce an electronic output that is unique to the medicament delivery devices contained within the container 310.


In some embodiments, for example, the first electronic output can be associated with an audible message including information contained from the signal S, such as for example, the expiration date of the medicament contained within the first medicament delivery device 350. Such an audible message can state, for example, “You have removed an auto-injector containing DOSE mg of Epinephrine. The expiration date of this device is EXPIRATION DATE. If the current date is later than EXPIRATION DATE please select another auto-injector from within the container.” In other embodiments, for example, the first electronic output can be a message providing the user with use instructions or other information contained within the signal S that is uniquely associated with the first medicament delivery device 350. For example, such a message can prompt a user to call a phone number unique to the manufacturer of the first medicament delivery device 350 for assistance before, during or after the use of the first medicament delivery device 350. In yet other embodiments, as described in more detail herein, the electronic circuit system 330 can automatically call such a phone number when the first medicament delivery device 350 is removed from the internal region 312 of the container 310.


The label 354 can be any device suitable for outputting the signal S that includes information associated with the first medicament delivery device 350 and that can be received by the electronic circuit system 330. For example, in some embodiments, the label 354 can include a passive RFID tag. In other embodiments, the label can include an active RFID tag.


In some embodiments, label 354 can include its own electronic circuit system, similar to the electronic circuit systems described in U.S. patent application Ser. No. 11/621,236, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Jan. 9, 2007, which is incorporated herein by reference in its entirety. In such embodiments, the label 354 can produce multiple signals associated with the first medicament delivery device 350 based on the ongoing status of the medicament delivery device 350 as determined by the electronic circuit system included within the label 354. For example, in some embodiments, the first medicament delivery device 350 can include its own electronic circuit system having various switches, sensors or the like, such that when the user completes certain operations (e.g., removing the needle guard, removing the safety tab, etc.), a signal S can be transmitted to the electronic circuit system 330 of the container 310. The electronic circuit system 330 of the container 310 can then output one or more electronic outputs of the type described above to provide information to the user that is unique to the status of the first medicament delivery device 350.


Although the label 354 is shown and described as outputting a signal S that can be received by the electronic circuit system 330, in other embodiments, the label 354 can be a passive device that does not output an electronic signal, but rather, contains information associated with the medicament delivery device 350 in a machine-readable format. For example, in such embodiments, the label 354 can include a bar code portion containing information associated with the medicament delivery device 350. In other embodiments, the label 354 can include a magnetic strip containing information associated with the medicament delivery device 350.


The electronic circuit systems shown and described above can include many components operatively coupled to perform the functions described herein For example, FIG. 8 is a schematic illustration of an electronic circuit system 430 according to an embodiment of the invention. The electronic circuit system 430 includes a processor 432 operatively coupled to a memory device 434. The memory device 434 can be configured to store processor-readable code 435 instructing the processor 432 to perform the functions described herein. In some embodiments, the processor-readable code 435 can be modified and/or updated as circumstances dictate. The electronic circuit system 430 includes an input/output device 446 configured to receive electronic inputs from a first switch 436 and/or a second switch 437. In some embodiments, the input/output device 446 can receive inputs from an RFID tag (as described above), the user's voice (e.g., through a microphone), a keyboard, a touch screen, a proximity sensor and/or any other suitable device. The input/output device 446 is also configured to provide electronic signals to various output devices, such as, for example, a visual output device 442, an audio output device 444, a haptic output device (not shown in FIG. 8) a wireless receiver (e.g., an RFID tag, a cellular phone system or the like) and/or a wired receiver (e.g., a wired network).


The visual output device 442 can be any suitable device for producing visual indicia, such as, light-emitting diodes (LEDs), liquid-crystal display (LCD) screens, optical polymers, fiber optic components or the like. Similarly, the audio output device 444 can be any suitable device for producing sound, such as a micro-speaker a piezo-electric transducer or the like. Such sound output can include, for example, an alarm, a series of beeps, recorded speech or the like.


In some embodiments, the electronic circuit system 430 includes a network interface 440 configured to operatively couple the electronic circuit system 430 to a remote device 441, either via a wired connection or via a wireless connection. The remote device 441 can be, for example, a remote communications network, a computer, a cell phone, a personal digital assistant (PDA) or the like. Such an arrangement can be used, for example, to download replacement processor-readable code 435 from a central network to the memory device 434. In some embodiments, the electronic circuit system 430 can download information associated with a medicament delivery device, such as an expiration date, a recall notice, updated use instructions or the like.


The network interface 440 can also be configured to transmit information from the electronic circuit system 430 to a central network, such as, for example, an emergency response network. In some embodiments, for example, the electronic circuit system 430 can notify an emergency responder when a medicament delivery device is removed and/or actuated. In other embodiments, the electronic circuit system 430 can transmit information to a third party, such as a physician, an emergency contact and/or the manufacturer of a medicament device, when the medicament delivery device is removed and/or actuated. Such information can include, for example, the location of use, the date and/or time of use or the like.


As shown in FIG. 8, power is supplied to the electronic circuit system 430 by a power source 448. The power source 448 can be any suitable power source, such as, for example, a DC power source and/or an AC power source. In some embodiments, for example, power can be provided to the electronic circuit system 430 by an AC circuit within the building in which the medical device is located. In other embodiments, power can be provided to the electronic circuit system 430 by one or more batteries. In yet other embodiments, power can be provided to the electronic circuit system 430 by both an AC circuit (e.g. as the primary source of power) and by batteries (e.g. as the secondary source of power). In yet other embodiments, the electronic circuit system 430 can be powered by any suitable energy storage device, such as, for example, a capacitor, solar cell or the like.


The processor 432 can be a commercially-available processing device dedicated to performing one or more specific tasks. For example, in some embodiments, the microprocessor 432 can be a commercially-available microprocessor, such as the Sonix SNC 12060 voice synthesizer. Alternatively, the processor 432 can be an application-specific integrated circuit (ASIC) or a combination of ASICs, which are designed to perform one or more specific functions. In yet other embodiments, the processor 132 can be an analog or digital circuit, or a combination of multiple circuits.


The memory device 434 can include one or more types of memory. For example, in some embodiments, the memory device 434 can include a read only memory (ROM) component and a random access memory (RAM) component. The memory device 432 can also include other types of memory suitable for storing data in a form retrievable by the processor 432, for example, electronically-programmable read only memory (EPROM), erasable electronically-programmable read only memory (EEPROM) and/or flash memory.


Although the medical devices shown and described above include one electronic circuit system, in some embodiments, a medical device can include multiple electronic circuit systems configured to perform the functions described herein.


Although the containers shown and described above include multiple medicament delivery devices, in some embodiments, a container can include only one medicament delivery device. For example, FIGS. 9-11 show a medical device 500 including a container 510 that contains a medicament delivery device 550, such as, for example a pen injector or an auto-injector. As described above, the container 510 defines an internal region 512 in which the medicament delivery device 550 is contained. The container includes an electronic circuit system 530 configured to produce one or more electronic outputs of the type described above. More particularly, the electronic circuit system 530 includes a speaker 544 and an LCD screen 542.


The container 510 also includes a movable portion 518, such as, for example, a hinged lid, that has a first position (see FIG. 9) and a second position (see FIGS. 10-11). When the movable portion 518 is in the first position, the movable portion 518 covers the internal region 512 of the container 510. Conversely, when the movable portion 518 is in the second position, at least a portion of the internal region 512 of the container 510 is exposed. Said another way, when the movable portion 518 is in the second position, the medicament delivery device 550 can be removed from the internal region 512 of the container 510.


The electronic circuit system 530 is operatively coupled to a first switch 536 and a second switch 537. The first switch 536 is configured to move between a first state (e.g., closed) and a second state (e.g., opened) when the movable portion 518 moves between its first position and its second position, as indicated by arrow E in FIG. 10. The electronic circuit system 530 is configured to output a first output OP5 via the speaker 544 when the first switch 536 is moved from its first state to its second state. The first output OP5 can be a recorded speech output associated with an identification of the medicament delivery device 550, an identification of patient symptoms (e.g., instructions for assessing the physical condition of the patient) and/or an instruction for using the medicament delivery device 550. For example, in some embodiments the first output OP5 can state “You have activated the allergic reaction response kit. This kit includes an auto-injector containing DOSE mg of Epinephrine. Before using this auto-injector, please ensure that the patient is exhibiting the following symptoms . . . ” Although described as an audible output, in other embodiments, the first output OP5 can be any type of electronic output as described above.


The second switch 537 is configured to move between a first state (e.g., closed) and a second state (e.g., opened) when the medicament delivery device 550 is removed from the internal region 512 of the container 510, as indicated by the arrow F in FIG. 11. The electronic circuit system 530 is configured to output a second output OP6 via the speaker 544 and/or the LCD screen 542 when the second switch 537 is moved from its first state to its second state. The second output OP6 can be, for example, a recorded speech output and/or a video output associated with an identification of the medicament delivery device 550, an identification of patient symptoms (e.g., instructions for assessing the physical condition of the patient) and/or an instruction for using the medicament delivery device 550. For example, in some embodiments the second output OP6 can be an audio-visual output via both the speaker 544 and the LCD screen 542 providing step-by-step instructions for using the medicament delivery device 550.


Although the movable member 518 is shown and described as being a hinged lid, in some embodiments, the movable member can be coupled to the container in any suitable fashion. For example, in some embodiments, the movable member 518 can be a removable cover that is slidingly coupled to the container. In other embodiments, the movable member 518 can be a removable cover that is threadedly coupled to the container (i.e., a removable cap). In yet other embodiments, the movable member 518 can be a removable cover that is coupled to the container via an interference fit. In yet other embodiments, the movable member 518 can be a frangible cover that is irreversibly removed from the container during use of the medical device. For example, in some embodiments the movable member 518 can be a frangible cover that provides a tamperproof seal, a sanitary seal, or the like.


Although the containers are shown and described above as being rigid, box-like containers, in other embodiments, a container can have any suitable shape and/or flexibility. For example, in some embodiments, a container can be a flexible, pouch-like container. Such a container can be more easily carried in certain circumstances, such as, for example at outdoor events (e.g., children's camps, concerts, picnics or the like). In other embodiments, a container can be a tube configured to contain all or a portion of a medicament delivery device. For example, FIGS. 12-14 show a medical device 600 including a tube-shaped container 610 and a retainer 618. The container 610 defines an internal region 612 (see FIG. 15) in which at least a portion of a medicament delivery device 650 can be contained.


The retainer 618, which can be, for example, a mating tube-shaped lid, is movably coupled to the container 610 to retain the medicament delivery device 650 within the internal region 612. Said another way, the retainer 618 has a first position (FIG. 12) and a second position (FIG. 13). When the retainer 618 is in the first position, the retainer 618 prevents the medicament delivery device 650 from being removed from the internal region 612 of the container 610. When the retainer 618 is in the second position, the medicament delivery device 650 can be removed from the internal region 612 of the container 610.


The medical device 600 includes an electronic circuit system 630 coupled to the container 610. The electronic circuit system 630 includes a speaker 644 and a light emitting diode (LED) 642 for providing an electronic output associated with the use of the medicament delivery device 650, as described herein. In some embodiments, the electronic circuit system can be, for example, a flexible circuit included in a label coupled to an outer surface of the container 610, similar to the electronic circuit systems described in U.S. patent application Ser. No. 11/621,236, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Jan. 9, 2007, which is incorporated herein by reference in its entirety.


The electronic circuit system 630 is configured to output a first electronic output via the LED 642 and/or the speaker 644 when the retainer 618 is moved relative to the container 610, as indicated by arrows G and/or G′ in FIG. 13. As described above, the first electronic output can be associated with an identification of the medicament delivery device 650, an identification of a physical condition and/or an instruction for using the medicament delivery device 650. For example, in some embodiments, the first electronic output can be associated with an audible message instructing a user in the use of the medicament delivery device 650. Such an audible message can state, for example, “You have activated an interactive auto-injector containing DOSE mg of Epinephrine. Please remove the top of the container by twisting and pulling as indicated by the flashing arrow. After removing the top of the container, please remove the auto-injector from the container by firmly pulling on the exposed end of the auto-injector.”


The electronic circuit system 630 can be prompted to output the first electronic output by a switch 636 configured to change states when the retainer 618 is moved relative to the container 610. The switch 636 can be any suitable electronic switch having at least two states. For example, in some embodiments, the switch 636 can be a single-use “tear-through” switch, as described in U.S. patent application Ser. No. 11/621,236, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Jan. 9, 2007, which is incorporated herein by reference in its entirety. For example, the switch 636 can be irreversibly moved from a first state to a second state when the retainer 618 is moved relative to the container 610. In other embodiments, a switch can be a multi-use switch, such as a microswitch.


Similarly, the electronic circuit system 630 is configured to output a second electronic output via the LED 642 and/or the speaker 644 when the medicament delivery device 650 is removed from the internal region 612 defined by the container 610, as shown by arrow H in FIG. 14. The second electronic output can be associated with an identification of the medicament delivery device 650, an identification of a physical condition and/or an instruction for using the medicament delivery device 650. For example, in some embodiments, the second electronic output can be an audible message stating, “To activate the auto-injector, first remove the needle guard. The needle guard is at the bottom of the auto-injector and contains the number one inside of an arrow pointing downward. Remove the needle guard by pulling in the direction of the arrow.”


As shown in FIG. 14, the medicament delivery device 650 includes a label 654 containing information associated with the medicament delivery device 650 arranged in a machine-readable format. The electronic circuit system 630 is configured to receive (e.g., “read”) the information contained in the label 654 and include at least a portion of the information in the first electronic output and/or the second electronic output. In this manner, the electronic circuit system 630 can be configured to produce an electronic output that is unique to the medicament delivery device 650 contained within the container 610. This arrangement allows the container 610 to be reused with any number of different medicament delivery devices 650. Moreover, this arrangement allows the container 610 to track the usage of a chronic-care medicament delivery devices. For example, in some embodiments, the electronic circuit system 630 can track each use of the medicament delivery device 650 and log such information on the label 654.


The label 654 can be any device suitable for containing information associated with the medicament delivery device 650 in a machine-readable format. For example, in some embodiments, the label 654 can include a bar code portion containing information associated with the medicament delivery device 650. In other embodiments, the label 654 can include a magnetic strip containing information associated with the medicament delivery device 650. In yet other embodiments, the label 654 can include a passive RFID tag containing information associated with the medicament delivery device 650. In yet other embodiments, the label 654 can include an active RFID tag containing information associated with the medicament delivery device 650.


Although the retainer 618 is shown as covering the internal region 612 defined by the container 610, in some embodiments, the retainer 618 can allow access to the internal region 612 while still retaining the medicament delivery device 650 within the internal region 612. For example, in some embodiments, the retainer 618 can be a clip, a strap or the like.


Although the medicament delivery device 650 is shown in FIGS. 12-13 as being disposed entirely within the container 610 and the retainer 618, in some embodiments, only a portion of the medicament delivery device 650 is disposed within the container 610 and/or the retainer 618. For example, in some embodiments, a container can be a sleeve configured to be disposed about a portion of a medicament delivery device, such as a chronic care pen injector. The retainer can function to retain the pen injector within the sleeve and/or to prevent the pen injector from being actuated (e.g., the retainer can act as a locking member). In use, the user can activate the electronic circuit system by depressing a start button disposed on the container. Alternatively, in some embodiments, the electronic circuit system can be activated by removing the retainer from the pen injector and/or the container. In yet other embodiments, the electronic circuit system can be activated by moving the pen injector relative to the container (i.e., twisting the pen injector within the container). Upon activation, the electronic circuit system then “reads” a label and outputs a first electronic output and/or a second electronic output, as described above.


While various embodiments of the invention have been described above, it should be understood that they have been presented by way of example only, and not limitation. Where methods described above indicate certain events occurring in certain order, the ordering of certain events may be modified. Additionally, certain of the events may be performed concurrently in a parallel process when possible, as well as performed sequentially as described above.


For example, although electronic circuit systems are shown and described above as outputting one or more outputs directed towards a single, immediate user, in some embodiments, an electronic circuit system can output multiple outputs directed towards multiple different classes of users. For example, in some embodiments, an electronic circuit system can output a first electronic output to the immediate user and second electronic output to a remotely located emergency response team. In such embodiments, the second electronic output can be, for example, a phone call, a page, an e-mail or the like. For example, in some embodiments, the second electronic output can be an e-mail to the parents and/or caregivers of a child. Moreover, such a second electronic output can be transmitted either wirelessly or through a wired network.


Although the electronic circuit systems are shown and described above as outputting one or more outputs in response to one or more switches, in other embodiments an electronic circuit system can output an electronic output in response to any number of different inputs. For example, in some embodiments, an electronic circuit system can output an electronic output based on input from the user provided via a keyboard, a touch screen, a microphone or any other suitable input device. In this manner, the electronic outputs can be produced in response to direct feedback from the user.


In other embodiments, an electronic circuit system can output an electronic output based on a sensor included in the container and/or the medicament delivery device. Such a sensor can include, for example, a proximity sensor (e.g., to determine the position of the medicament delivery device), a temperature sensor, a pressure sensor, an optical sensor or the like. For example, in some embodiments, the container can include a temperature sensor configured to sense the temperature of the medicament contained within the medicament delivery device. In this manner, the electronic circuit system can output an instruction and/or a status message when the medicament is too cold for effective delivery. For example, in some embodiments, when the medicament is too cold for effective delivery (this may occur, for example, if the container is being used in an outdoor setting), the electronic circuit system can output a message, such as, for example, “Medicament is too cold—please briskly rub the auto-injector between your hands before using.”


Although the electronic circuit systems are shown and described above as outputting a single electronic output in response to an input (e.g., the removal of a medicament delivery device, the change in position of a hinged lid, etc.), in some embodiments, an electronic circuit system can output a sequence of electronic outputs in response to such an input. In some embodiments, for example, when a medicament delivery device is removed from a container, an electronic circuit system can output a predetermined sequence of use instructions over a predetermined time period. For example, upon removing the medicament delivery device, the first instruction can be an audible output indicating the type of medicament delivery device removed. After a predetermined time period, the electronic circuit system can then output a second instruction, which can be a visual output instructing the user in how to diagnose the patient and/or prepare the patient for the medicament. In a similar manner, the electronic circuit system can provide additional outputs to instruct the user in the use of the medicament delivery device. Moreover, in some embodiments, the electronic circuit system can output an electronic output instructing the user in post-use procedures, such as for example, the disposal of the medicament delivery device, instructions for follow-up treatment or the like.


For example, although the electronic circuit systems are shown and described above as being configured to output primarily audible and visual outputs, in other embodiments, an electronic circuit system can be configured to produce any suitable output. For example, in some embodiments, an electronic circuit system can produce a haptic output, such as a vibratory output produced by a piezo-electric actuator. In other embodiments, an electronic circuit system can produce a thermal output, produced by a heating or cooling element.


Although the electronic circuit systems are shown and described above as outputting recorded speech in English, in other embodiments, the electronic circuit system can output recorded speech in any language. In yet other embodiments, the electronic circuit system can output recorded speech in multiple languages. In yet other embodiments, the user can select the language in which the recorded speech is to be output.


Although the medicament delivery devices have been shown and described above as being primarily single-use medical injectors, in some embodiments a medicament delivery device can include any suitable device for delivering one or more doses of a medicament into a patient's body. For example, in some embodiments, a medicament delivery device can be a pen injector containing multiple doses of a chronic-care medicament, such as, for example, insulin. In such embodiments, an electronic circuit system can output instructions associated with not only an initial use of the medicament delivery device, but also associated with repeated uses, dosage monitoring or the like. In other embodiments, a medicament delivery device can include a transdermal medicament delivery device, an inhaler or a nasal medicament delivery device.


Although various embodiments have been described as having particular features and/or combinations of components, other embodiments are possible having a combination of any features and/or components from any of embodiments where appropriate. For example, in some embodiments a medical device can include a container including an electronic circuit system, two or more medicament delivery devices and a movable portion. In such embodiments, each of the medicament delivery devices can be associated with a switch. Moreover, the movable portion can also be associated with a switch. In this manner, the electronic circuit system can be configured to output a first electronic output when the movable portion is moved, a second electronic output when the first medicament delivery device is removed from the container and a third electronic output when the second medicament delivery device is removed from the container.

Claims
  • 1. An apparatus, comprising: a container defining an internal region configured to contain at least a portion of a medicament delivery device, the container including an electronic circuit system including a switch, the electronic circuit system configured to receive an input from at least one of a microphone or an electronic visual display, the electronic circuit system configured to output a first electronic output associated with the input, the electronic circuit system configured to output a second electronic output associated with the medicament delivery device when the switch is moved from a first state to a second state, the container including a mounting portion configured to be coupled to a structure such that the electronic circuit system is operably coupled to a power source associated with the structure; anda movable member configured to be movably coupled to the container, the movable member configured to maintain the portion of the medicament delivery device within the internal region, a portion of the movable member configured to move the switch from the first state to the second state when the movable member is moved relative to the container.
  • 2. The apparatus of claim 1, wherein at least one of the first electronic output or the second electronic output is associated with at least one of an identification of the medicament delivery device, an identification of a physical condition or an instruction for using the medicament delivery device.
  • 3. The apparatus of claim 1, wherein at least one of the first electronic output or the second electronic output is a wireless communications signal.
  • 4. The apparatus of claim 1, further comprising; the electronic visual display, at least one of the first electronic output or the second electronic output includes a visual output produced by the electronic visual display.
  • 5. The apparatus of claim 1, wherein at least one of the first electronic output or the second electronic output includes a recorded speech output.
  • 6. The apparatus of claim 1, wherein the switch is a first switch, the electronic circuit system includes a second switch, the apparatus further comprising: a retainer configured to retain the medicament delivery device within the internal region, the electronic circuit system includes a second switch associated with the retainer, a portion of the retainer configured to move the second switch between a first state and a second state when the retainer is moved relative to the container, the electronic circuit system configured to output a third electronic output when the second switch moves between its first state and its second state.
  • 7. The apparatus of claim 1, wherein: the medicament delivery device includes a label configured to output a signal configured to be received by the electronic circuit system, the signal associated with at least one of a location of the medicament delivery device, a contents of the medicament delivery device, an expiration date of the medicament delivery device, a dosage of the medicament delivery device or a use instruction associated with the medicament delivery device; andat least one of the first electronic output or the second electronic output is associated with the signal received by the electronic circuit system.
  • 8. The apparatus of claim 1, further comprising: the electronic visual display coupled to the movable member, at least one of the first electronic output or the second electronic output includes a visual output produced by the electronic visual display.
  • 9. An apparatus, comprising: a container defining an internal region configured to contain at least a portion of a medicament delivery device, the container including a mounting portion;a movable member configured to be movably coupled to the container, the movable member configured to limit movement of the medicament delivery device; andan electronic circuit system coupled to the container, the mounting portion of the container configured to be coupled to a structure such that the electronic circuit system is operably coupled to a power source associated with the structure, the electronic circuit system including an electronic visual display and a speaker, the electronic circuit system configured to produce a first output via at least one of the electronic visual display or the speaker, the electronic circuit system configured to produce a second output in response to an input received from at least one of a microphone or the electronic visual display, the electronic circuit system configured to produce a third output when the movable member is moved.
  • 10. The apparatus of claim 9, wherein the electronic visual display is coupled to the movable member.
  • 11. The apparatus of claim 9, wherein at least one of the second output or the third output includes a wireless communications signal.
  • 12. The apparatus of claim 9, wherein at least one of the first output, the second output or the third output includes a recorded speech output.
  • 13. The apparatus of claim 9, wherein: the electronic circuit system including a switch disposed on a printed circuit board, the electronic circuit system configured to produce the third output when the switch is moved from a first state to a second state; andthe movable member is configured to retain a portion of the medicament delivery device within the internal region, a portion of the movable member configured to engage a portion of the printed circuit board to move the switch from the first state to the second state when the movable member is moved relative to the container.
  • 14. The apparatus of claim 9, further comprising: a battery disposed within the container, the battery configured to be operably coupled to the electronic circuit system.
  • 15. An apparatus, comprising: a container defining an internal region configured to contain at least a portion of a medicament delivery device, the container including a mounting portion;a movable member configured to be movably coupled to the container, the movable member configured to limit movement of the medicament delivery device; andan electronic circuit system coupled to the container, the mounting portion of the container configured to be coupled to a structure such that the electronic circuit system is operably coupled to a power source associated with the structure, the electronic circuit system including a switch and an electronic visual display, the electronic circuit system configured to receive an input from at least one of a microphone or the electronic visual display, the electronic circuit system configured to produce a first electronic output associated with the input, the electronic circuit system configured to produce a second electronic output when the switch is moved from a first state to a second state,a portion of the movable member configured to move the switch from the first state to the second state when the movable member is moved relative to the container.
  • 16. The apparatus of claim 15, wherein the electronic visual display is coupled to the movable member.
  • 17. The apparatus of claim 15, further comprising: a battery disposed within the container, the battery configured to be operably coupled to the electronic circuit system.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 11/671,025, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Feb. 5, 2007, which is a continuation-in-part of U.S. patent application Ser. No. 11/621,236, now U.S. Pat. No. 7,731,686, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Jan. 9, 2007, which claims priority to U.S. Provisional Application Ser. No. 60/787,046, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Mar. 29, 2006, which is incorporated herein by reference in its entirety. U.S. patent application Ser. No. 11/621,236 is a continuation-in-part of U.S. patent application Ser. No. 10/572,148, now U.S. Pat. No. 7,749,194, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Mar. 16, 2006, which is a national stage filing under 35 U.S.C. §371 of International Patent Application No. PCT/US2006/003415, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Feb. 1, 2006, which claims priority to U.S. Provisional Application Ser. No. 60/648,822, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Feb. 1, 2005 and U.S. Provisional Application Ser. No. 60/731,886, entitled “Auto-Injector with Feedback,” filed Oct. 31, 2005, each of which is incorporated herein by reference in its entirety.

US Referenced Citations (340)
Number Name Date Kind
2960087 Uytenbogaart Nov 1960 A
3055362 Uytenbogaart Sep 1962 A
3115133 Morando Dec 1963 A
3426448 Sarnoff Feb 1969 A
3688765 Gasaway Sep 1972 A
3768472 Hodosh et al. Oct 1973 A
3795061 Sarnoff et al. Mar 1974 A
3945379 Pritz et al. Mar 1976 A
4108177 Pistor Aug 1978 A
4149394 Sornes Apr 1979 A
4360019 Portner et al. Nov 1982 A
4424057 House Jan 1984 A
4441629 Mackal Apr 1984 A
4484910 Sarnoff Nov 1984 A
4573976 Sampson et al. Mar 1986 A
4596556 Morrow et al. Jun 1986 A
4610666 Pizzino Sep 1986 A
4613328 Boyd Sep 1986 A
4617557 Gordon Oct 1986 A
4624660 Mijers et al. Nov 1986 A
4640686 Dalling et al. Feb 1987 A
4643721 Brunet Feb 1987 A
4666430 Brown et al. May 1987 A
4673657 Christian Jun 1987 A
4689042 Sarnoff et al. Aug 1987 A
4693708 Wanderer et al. Sep 1987 A
4781697 Slaughter Nov 1988 A
4782841 Lopez Nov 1988 A
4784652 Wikström Nov 1988 A
4795433 Sarnoff Jan 1989 A
4853521 Claeys et al. Aug 1989 A
4865582 Sibalis Sep 1989 A
4874382 Lindemann et al. Oct 1989 A
4894054 Miskinyar Jan 1990 A
4906235 Roberts Mar 1990 A
4915695 Koobs Apr 1990 A
4941880 Burns Jul 1990 A
4959056 Dombrowski et al. Sep 1990 A
4968302 Schluter et al. Nov 1990 A
4983164 Hook et al. Jan 1991 A
5000736 Kaufhold, Jr. et al. Mar 1991 A
5024656 Gasaway et al. Jun 1991 A
5037306 van Schoonhoven Aug 1991 A
5038023 Saliga Aug 1991 A
5041088 Ritson et al. Aug 1991 A
5062603 Smith et al. Nov 1991 A
5064413 McKinnon et al. Nov 1991 A
5071353 van der Wal Dec 1991 A
5085642 Sarnoff et al. Feb 1992 A
5092843 Monroe et al. Mar 1992 A
5125898 Kaufhold, Jr. et al. Jun 1992 A
5167641 Schmitz Dec 1992 A
5199949 Haber et al. Apr 1993 A
5224936 Gallagher Jul 1993 A
5240146 Smedley et al. Aug 1993 A
5281198 Haber et al. Jan 1994 A
5286258 Haber et al. Feb 1994 A
5298023 Haber et al. Mar 1994 A
5312326 Myers et al. May 1994 A
5314412 Rex May 1994 A
5314502 McNichols et al. May 1994 A
5343519 Feldman Aug 1994 A
5344407 Ryan Sep 1994 A
5354284 Haber et al. Oct 1994 A
5356376 Milijasevic et al. Oct 1994 A
5363842 Mishelevich et al. Nov 1994 A
5380281 Tomellini et al. Jan 1995 A
5383851 McKinnon, Jr. et al. Jan 1995 A
5394866 Ritson et al. Mar 1995 A
5399163 Peterson et al. Mar 1995 A
5405362 Kramer et al. Apr 1995 A
5417660 Martin May 1995 A
5466217 Myers et al. Nov 1995 A
5514135 Earle May 1996 A
5558679 Tuttle Sep 1996 A
5567160 Massino Oct 1996 A
5568555 Shamir Oct 1996 A
5569192 van der Wal Oct 1996 A
5584815 Pawelka et al. Dec 1996 A
5615771 Hollister Apr 1997 A
5616132 Newman Apr 1997 A
5645534 Chanoch Jul 1997 A
5662612 Niehoff Sep 1997 A
5681291 Galli Oct 1997 A
5692492 Bruna et al. Dec 1997 A
5695476 Harris Dec 1997 A
5697916 Schraga Dec 1997 A
5716338 Hjertman et al. Feb 1998 A
5772635 Dastur et al. Jun 1998 A
5792190 Olson et al. Aug 1998 A
5800397 Wilson et al. Sep 1998 A
5805423 Wever et al. Sep 1998 A
5809997 Wolf Sep 1998 A
5813397 Goodman et al. Sep 1998 A
5814020 Gross Sep 1998 A
5823363 Cassel Oct 1998 A
5832488 Eberhardt Nov 1998 A
5837546 Allen et al. Nov 1998 A
RE35986 Ritson et al. Dec 1998 E
5846089 Weiss et al. Dec 1998 A
5848988 Davis Dec 1998 A
5852590 de la Huerga Dec 1998 A
5853292 Eggert et al. Dec 1998 A
5868713 Klippenstein Feb 1999 A
5868721 Marinacci et al. Feb 1999 A
D407487 Greubel et al. Mar 1999 S
5925021 Castellano et al. Jul 1999 A
5928195 Malamud Jul 1999 A
5941857 Nguyen et al. Aug 1999 A
5964739 Champ Oct 1999 A
5970457 Brant et al. Oct 1999 A
5971953 Bachynsky Oct 1999 A
5991655 Gross et al. Nov 1999 A
6015438 Shaw Jan 2000 A
6039713 Botich et al. Mar 2000 A
6045534 Jacobsen et al. Apr 2000 A
6062901 Liu et al. May 2000 A
6063053 Castellano et al. May 2000 A
6074213 Hon Jun 2000 A
6077106 Mish Jun 2000 A
6084526 Blotky et al. Jul 2000 A
6086562 Jacobsen et al. Jul 2000 A
6096002 Landau Aug 2000 A
6099504 Gross et al. Aug 2000 A
6102896 Roser Aug 2000 A
6119684 Nöhl et al. Sep 2000 A
6149626 Rachynsky et al. Nov 2000 A
6158613 Novosel et al. Dec 2000 A
6161281 Dando et al. Dec 2000 A
6165155 Jacobsen et al. Dec 2000 A
6175752 Say Jan 2001 B1
6179812 Botich et al. Jan 2001 B1
6192891 Gravel et al. Feb 2001 B1
6193695 Rippstein, Jr. Feb 2001 B1
6202642 McKinnon et al. Mar 2001 B1
6210359 Patel et al. Apr 2001 B1
6210369 Wilmot et al. Apr 2001 B1
6219587 Ahlin et al. Apr 2001 B1
6221045 Duchon et al. Apr 2001 B1
6221055 Shaw et al. Apr 2001 B1
6245046 Sibbitt Jun 2001 B1
6258063 Haar et al. Jul 2001 B1
6259654 de la Huerga Jul 2001 B1
6264629 Landau Jul 2001 B1
6270455 Brown Aug 2001 B1
6284765 Caffrey Sep 2001 B1
6312412 Saied et al. Nov 2001 B1
6317630 Gross et al. Nov 2001 B1
6321654 Robinson Nov 2001 B1
6334070 Nova et al. Dec 2001 B1
6364866 Furr et al. Apr 2002 B1
6371939 Bergens et al. Apr 2002 B2
6377848 Garde et al. Apr 2002 B1
6387078 Gillespie, III May 2002 B1
6398760 Danby Jun 2002 B1
6405912 Giannou Jun 2002 B2
6411567 Niemiec et al. Jun 2002 B1
6413236 Van Dyke Jul 2002 B1
6425897 Overes et al. Jul 2002 B2
6428517 Hochman et al. Aug 2002 B1
6428528 Sadowski Aug 2002 B2
6475181 Potter et al. Nov 2002 B1
6478769 Parker Nov 2002 B1
6478771 Lavi et al. Nov 2002 B1
6494863 Shaw et al. Dec 2002 B1
6500150 Gross et al. Dec 2002 B1
6514230 Munk et al. Feb 2003 B1
6529446 de la Huerga Mar 2003 B1
6530900 Sahar et al. Mar 2003 B1
6530904 Edwards et al. Mar 2003 B1
6535714 Melker et al. Mar 2003 B2
6540672 Simonsen et al. Apr 2003 B1
6540675 Aceti et al. Apr 2003 B2
6544234 Gabriel Apr 2003 B1
6551276 Mann et al. Apr 2003 B1
6551298 Zhang et al. Apr 2003 B1
6554798 Mann et al. Apr 2003 B1
6558320 Causey, III et al. May 2003 B1
6560471 Heller et al. May 2003 B1
6565533 Smith et al. May 2003 B1
6569123 Alchas May 2003 B2
6572584 Shaw et al. Jun 2003 B1
6574166 Niemiec Jun 2003 B2
6575939 Brunel Jun 2003 B1
RE38189 Walker et al. Jul 2003 E
6585685 Staylor et al. Jul 2003 B2
6585698 Packman et al. Jul 2003 B1
6589158 Winkler Jul 2003 B2
6595956 Gross et al. Jul 2003 B1
6633796 Pool et al. Oct 2003 B1
6641566 Douglas et al. Nov 2003 B2
6645181 Lavi et al. Nov 2003 B1
6659980 Moberg et al. Dec 2003 B2
6679862 Diaz et al. Jan 2004 B2
6689093 Landau Feb 2004 B2
6702778 Hill et al. Mar 2004 B2
6707763 Osberg et al. Mar 2004 B2
6708050 Carim Mar 2004 B2
6722916 Buccinna et al. Apr 2004 B2
6723077 Pickup et al. Apr 2004 B2
6726661 Munk et al. Apr 2004 B2
6736796 Shekalim May 2004 B2
6743635 Neel et al. Jun 2004 B2
6749437 Chan Jun 2004 B2
6752781 Landau et al. Jun 2004 B2
6767336 Kaplan Jul 2004 B1
6770052 Hill et al. Aug 2004 B2
6783509 Landau et al. Aug 2004 B1
6786875 Barker et al. Sep 2004 B2
6786885 Hochman et al. Sep 2004 B2
6793646 Giambattista et al. Sep 2004 B1
6803856 Murphy et al. Oct 2004 B1
6808514 Schneider et al. Oct 2004 B2
6809653 Mann et al. Oct 2004 B1
6817986 Slate et al. Nov 2004 B2
6830560 Gross et al. Dec 2004 B1
6839304 Niemiec et al. Jan 2005 B2
6872200 Mann et al. Mar 2005 B2
6875195 Choi Apr 2005 B2
6883222 Landau Apr 2005 B2
6923764 Aceti et al. Aug 2005 B2
6936029 Mann et al. Aug 2005 B2
6937150 Medema et al. Aug 2005 B2
6942646 Langley et al. Sep 2005 B2
6946299 Neel et al. Sep 2005 B2
6949082 Langley et al. Sep 2005 B2
6952604 DeNuzzio et al. Oct 2005 B2
6953445 Wilmot et al. Oct 2005 B2
6953693 Neel et al. Oct 2005 B2
6958691 Anderson et al. Oct 2005 B1
6959247 Neel et al. Oct 2005 B2
6961285 Niemiec et al. Nov 2005 B2
6969259 Pastrick et al. Nov 2005 B2
6979316 Rubin et al. Dec 2005 B1
6979326 Mann et al. Dec 2005 B2
6985870 Martucci et al. Jan 2006 B2
6997911 Klitmose Feb 2006 B2
7014470 Vann Mar 2006 B2
7093595 Nesbitt Aug 2006 B2
7113101 Petersen et al. Sep 2006 B2
7116233 Zhurin Oct 2006 B2
7126879 Snyder Oct 2006 B2
7158011 Brue Jan 2007 B2
7191916 Clifford et al. Mar 2007 B2
7229458 Boecker et al. Jun 2007 B2
7278983 Ireland et al. Oct 2007 B2
7299981 Hickle et al. Nov 2007 B2
7343914 Abrams et al. Mar 2008 B2
7351223 Call Apr 2008 B2
7416540 Edwards et al. Aug 2008 B2
7544188 Edwards et al. Jun 2009 B2
7648482 Edwards et al. Jan 2010 B2
7648483 Edwards et al. Jan 2010 B2
7670328 Miller et al. Mar 2010 B2
7731686 Edwards et al. Jun 2010 B2
7731690 Edwards et al. Jun 2010 B2
7749194 Edwards et al. Jul 2010 B2
7947017 Edwards et al. May 2011 B2
8021344 Edwards et al. Sep 2011 B2
8123719 Edwards et al. Feb 2012 B2
8172082 Edwards et al. May 2012 B2
8231573 Edwards et al. Jul 2012 B2
20010005781 Bergens et al. Jun 2001 A1
20020072784 Sheppard, Jr. et al. Jun 2002 A1
20020074345 Schneider et al. Jun 2002 A1
20020076679 Aman Jun 2002 A1
20020090601 Strupat et al. Jul 2002 A1
20020096543 Juselius Jul 2002 A1
20020183721 Santini, Jr. et al. Dec 2002 A1
20030028145 Duchon et al. Feb 2003 A1
20030040717 Saulenas et al. Feb 2003 A1
20030106824 Wilmot et al. Jun 2003 A1
20030132128 Mazur Jul 2003 A1
20030233070 De La Serna et al. Dec 2003 A1
20040015125 Alexandre et al. Jan 2004 A1
20040019326 Gilbert et al. Jan 2004 A1
20040039336 Amark et al. Feb 2004 A1
20040039337 Letzing Feb 2004 A1
20040039368 Reilly et al. Feb 2004 A1
20040069667 Tomellini et al. Apr 2004 A1
20040116854 Abulhaj et al. Jun 2004 A1
20040138611 Griffiths et al. Jul 2004 A1
20040143298 Nova et al. Jul 2004 A1
20040159364 Landau et al. Aug 2004 A1
20040220524 Sadowski et al. Nov 2004 A1
20040249358 McWethy et al. Dec 2004 A1
20040267204 Brustowicz Dec 2004 A1
20050033234 Sadowski et al. Feb 2005 A1
20050033386 Osborn et al. Feb 2005 A1
20050055014 Coppeta et al. Mar 2005 A1
20050062603 Fuerst et al. Mar 2005 A1
20050088289 Rochkind Apr 2005 A1
20050090781 Baba et al. Apr 2005 A1
20050134433 Sweeney, II Jun 2005 A1
20050137530 Campbell et al. Jun 2005 A1
20050148931 Juhasz Jul 2005 A1
20050148945 Chen Jul 2005 A1
20050159705 Crawford et al. Jul 2005 A1
20050165360 Stamp Jul 2005 A1
20050168337 Mahoney Aug 2005 A1
20050171477 Rubin et al. Aug 2005 A1
20050182358 Veit et al. Aug 2005 A1
20050186221 Reynolds et al. Aug 2005 A1
20050197654 Edman et al. Sep 2005 A1
20050261742 Nova et al. Nov 2005 A1
20050267403 Landau et al. Dec 2005 A1
20050277891 Sibbitt Dec 2005 A1
20060030819 Young et al. Feb 2006 A1
20060053036 Coffman et al. Mar 2006 A1
20060058848 Piraino et al. Mar 2006 A1
20060111666 Hommann et al. May 2006 A1
20060111671 Klippenstein May 2006 A1
20060116639 Russell Jun 2006 A1
20060129090 Moberg et al. Jun 2006 A1
20060169611 Prindle Aug 2006 A1
20060189938 Hommann et al. Aug 2006 A1
20060200077 Righi et al. Sep 2006 A1
20060247579 Friedman Nov 2006 A1
20060265186 Holland et al. Nov 2006 A1
20070008113 Spoonhower et al. Jan 2007 A1
20070074722 Giroux et al. Apr 2007 A1
20070184847 Hansen et al. Aug 2007 A1
20070203247 Phillips et al. Aug 2007 A1
20070210147 Morrone et al. Sep 2007 A1
20070213598 Howard et al. Sep 2007 A1
20070233001 Burroughs et al. Oct 2007 A1
20070239116 Follman et al. Oct 2007 A1
20070260210 Conroy Nov 2007 A1
20080059133 Edwards et al. Mar 2008 A1
20080111685 Olson et al. May 2008 A1
20080160492 Campbell et al. Jul 2008 A1
20080230057 Sutherland Sep 2008 A1
20090024112 Edwards et al. Jan 2009 A1
20090176834 Kottayil et al. Jul 2009 A1
20090240200 Heneveld et al. Sep 2009 A1
20100211005 Edwards et al. Aug 2010 A1
20120008811 Edwards et al. Jan 2012 A1
20120226226 Edwards et al. Sep 2012 A1
20130023822 Edwards et al. Jan 2013 A1
20130023825 Edwards et al. Jan 2013 A1
Foreign Referenced Citations (28)
Number Date Country
1043037 Oct 2000 EP
1287840 Mar 2003 EP
1462134 Sep 2004 EP
1712178 Oct 2006 EP
55-75335 Jun 1980 JP
2003-310758 Nov 2003 JP
2006-034845 Feb 2006 JP
WO 9104760 Apr 1991 WO
WO9302720 Feb 1993 WO
WO 9526009 Sep 1995 WO
WO 9730742 Aug 1997 WO
WO 9907425 Feb 1999 WO
WO 9943283 Sep 1999 WO
WO 0124690 Apr 2001 WO
WO 0126020 Apr 2001 WO
WO 0141849 Jun 2001 WO
WO 0188828 Nov 2001 WO
WO 0193926 Dec 2001 WO
WO 0224257 Mar 2002 WO
WO 02051471 Jul 2002 WO
WO 03057283 Jul 2003 WO
WO 03095001 Nov 2003 WO
WO 03097133 Nov 2003 WO
WO 2004041330 May 2004 WO
WO 2005050526 Jun 2005 WO
WO 2006045525 May 2006 WO
WO 2006109778 Oct 2006 WO
WO2006125692 Nov 2006 WO
Non-Patent Literature Citations (34)
Entry
“Solutions for Medical Devices,” © 3M Brochure, © 3M 2006 80-6201-3490-0.
Merle Tingelstad, “Revolutionary Medical Technology Increases Demand for Flexible Interconnects,” [online] May 15, 2006 [retrieved on Nov. 15, 2006] Retrieved from the Internet <URL: http://www.ecnmag.com/index.asp?layout=articlePrint&ArticleID=CA6332947 >.
“Flexible circuits / Flex circuits / Flexible Technology Ltd.,” Flexible Technology Limited [online] [retrieved on Aug. 28, 2006] Retrieved from the Internet <URL: http://www.flexibletechnology.com/ >.
“Flexible circuits capabilities of Flexible Technology Limited,” Our Flexible Circuits Capabilities [online] [retrieved on Aug. 28, 2006] Retrieved from the Internet <URL: http://www.flexibletechnology.com/Flexible circuits Capability.htm >.
“Flex Circuits/flexible circuits design guide,” [online] [retrieved on Aug. 28, 2006] Retrieved from the Internet <URL: http://flexiblecircuit.co.uk/Flex Circuits Design Guide.htm >.
“Insect Stings Auto-injector Pouches and Carry Cases,” The Insect Stings On-Line Shop, [online] [retrieved on Jan. 24, 2007] Retrieved from the Internet <URL: http://www.insectstings.co.uk/acatalog/Auto Injector Pouches.html >.
“Anaphylaxis Canada Product Catalogue,” Anaphylaxis Canada > Living with Anaphylaxis > Tools and Resources [online] [retrieved on Jan. 24, 2007] Retrieved from the Internet <URL: http://anaphylaxis.org/content/livingwith/productcatalogue.asp >.
“Microfluidics Device Provides Programmed, Long-Term Drug Dosing,” nano techwire.com [online] [retrieved on Nov. 28, 2006] Retrieved from the Internet <URL: http://nanotechwire.com/news.asp?nid=3141&ntid=124&pg=1 >.
Roger Allan, “Medical Electronics: Technology Advances Will Revolutionize Healthcare,” Sep. 30, 2002 [online] [retrieved on Nov. 28, 2006] Retrieved from the Internet <URL: http://www.elecdesign.com/Articles/Index.cfm?AD=1&ArticleID=2041>.
RFID Gazette, “Smart Labels in Healthcare,” Sep. 29, 2005 [online] [retrieved on Nov. 28, 2006] Retrieved from the Internet <URL: http://www.rfidagazeete.org/2005/09/smart labels in.html >.
“Merck Serono Launches easypod(R), First Electronic Growth Hormone Injection Device,” Jan. 30, 2007 [online] [retrieved on Feb. 5, 2007] Retrieved from the Internet <URL: http://www.biz.yahoo.com/prnews/070130/ukm028.html?.v=8.
Dr. Oliver Scholz, “Drug depot in a tooth,” [online] [retrieved on Feb. 6, 2007] Retrieved from the Internet <URL: http://www.fraunhofer.de/fhg/EN/press/pi/2007/02Mediendienst22007Thema2.jsp?print=true.
Heartsine Technology, samaritan™ Pad Accessories [online] [retrieved on Jun. 1, 2007] Retrieved from the Internet <URL: http://www.heartsine.com/aboutsam-accessories.htm>.
CliniSense Corporation, “Drug delivery devices a potentially harsh environment for drugs,” Stability [online] [retrieved on Jun. 1, 2007] Retrieved from the Internet <URL: http://www.clinisense.com/devices.htm>.
CliniSense Corporation, “LifeTrack Technology a new method to detect improper storage.” Stability [online] [retrieved on Jun. 1, 2007] Retrieved from the Internet <URL: http://www.clinisense.com/tech.htm>.
AED Professionals™ Brochure [online] [retrieved on Jun. 1, 2007] Retrieved from the Internet <URL: http://www.aedprofessionals.com/>.
Daniel Ruppar, “Implant Technologies Expected to Remain a Niche but Effective Method of Drug Delivery,” Drug Delivery Technology, Feb. 2007, vol. 7, No. 2 [online] [retrieved on Jun. 1, 2007] Retrieved from the Internet <URL: http://www.drugdeliverytech-online.com/drugdelivery/200702/templates/pageviewer—print?pg=44&pm=8 >.
Search Report and Written Opinion for International Patent Application No. PCT/US06/03415 mailed Jul. 13, 2006, 10 pages.
Search Report and Written Opinion for International Patent Application No. PCT/US07/007626 mailed Sep. 29, 2008.
Combined Search and Examination Report for GB 0818178.6, mailed Dec. 1, 2008.
Office Action for U.S. Appl. No. 11/621,236, mailed Feb. 3, 2009.
Examination Report for British Patent Application No. GB 0818178.6, mailed Mar. 23, 2009.
Examination Report for British Patent Application No. GB 0905194.7, mailed May 8, 2009.
Final Office Action for U.S. Appl. No. 11/621,236, mailed Jul. 1, 2009.
Examination Report for British Patent Application No. GB 0818178.6, mailed Jul. 9, 2009.
Search Report and Written Opinion for International Patent Application No. PCT/US09/63983, mailed Feb. 25, 2010.
Search Report for European Patent Application No. 09150135.3, mailed Mar. 15, 2010.
Final Office Action for U.S. Appl. No. 11/679,331, mailed Feb. 15, 2011.
Office Action for Japanese Patent Application No. JP2009-502964, mailed May 23, 2011.
Final Office Action for U.S. Appl. No. 11/671,025, mailed Sep. 8, 2011.
English Translation of Office Action for Japanese Patent Application No. 2011-509613, mailed May 15, 2013.
Non-Final Office Action for U.S. Appl. No. 13/036,720, mailed May 17, 2013.
Non-Final Office Action for U.S. Appl. No. 13/234,649, mailed May 28, 2013.
English Translation of Office Action for Indian Patent Application No. 5414/DELNP/2007, mailed May 21, 2013.
Related Publications (1)
Number Date Country
20120280815 A1 Nov 2012 US
Provisional Applications (3)
Number Date Country
60648822 Feb 2005 US
60731886 Oct 2005 US
60787046 Mar 2006 US
Continuations (1)
Number Date Country
Parent 11671025 Feb 2007 US
Child 13464234 US
Continuation in Parts (2)
Number Date Country
Parent 11621236 Jan 2007 US
Child 11671025 US
Parent 10572148 US
Child 11621236 US